FTC Submits Comment Supporting Proposed FDA Guidance on Interchangeable Biosimilar Drugs
Date
The Federal Trade Commission submitted a comment supporting the Food and Drug Administration’s (FDA) draft guidance regarding interchangeable biosimilar drugs that can be substituted for brand-name...